Universe Pharmaceuticals annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals Debt-to-Assets Ratio Growth & History (UPC)
Universe Pharmaceuticals's debt-to-assets ratio was 0.13 for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 0.13 | 0.05 | +54.98% |
| 2024 | 2024-09-30 | 0.09 | −0.05 | −34.41% |
| 2023 | 2023-09-30 | 0.13 | 0.07 | +98.75% |
| 2022 | 2022-09-30 | 0.07 | 0.00 | +6.99% |
| 2021 | 2021-09-30 | 0.06 | −0.03 | −32.73% |
| 2020 | 2020-09-30 | 0.09 | — | — |
Universe Pharmaceuticals quarterly debt-to-assets ratio
Q4.20
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-03-31 | 0.13 | 0.04 | +39.49% |
| Q4 2025 | 2025-09-30 | 0.13 | 0.05 | +54.98% |
| Q2 2025 | 2025-03-31 | 0.10 | — | — |
| Q4 2024 | 2024-09-30 | 0.09 | −0.05 | −34.41% |
| Q4 2023 | 2023-09-30 | 0.13 | 0.07 | +98.75% |
| Q2 2023 | 2023-03-31 | 0.06 | −0.00 | −6.24% |
| Q4 2022 | 2022-09-30 | 0.07 | 0.00 | +6.99% |
| Q2 2022 | 2022-03-31 | 0.06 | — | — |
| Q4 2021 | 2021-09-30 | 0.06 | −0.03 | −32.73% |
| Q4 2020 | 2020-09-30 | 0.09 | — | — |
Universe Pharmaceuticals debt-to-assets ratio trends
Over the last five fiscal years, Universe Pharmaceuticals's debt-to-assets ratio increased from 0.09 to 0.13, a change of 0.04. The latest reported quarter, Q2 2026, shows 0.13.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗